Skip to main content
SpringerLink
Log in

Systemic and Endocrine Effects of Endothelin in Humans

  • Chapter
The Endothelium in Cardiovascular Disease

  • 62 Accesses

Abstract

The endothelium is the key to a complex system of neural and humoral factors modulating vascular smooth muscle tone by producing both relaxing and constrictive factors including the three currently known members of the endothelin family, endothelin-1 (ET-1 [1]), ET-2 and ET-3. These three structurally related peptides correspond to two types of receptors, designated ETA and ETB. The hemodynamic effects of endothelin-1 have been extensively studied in various animal models. Furthermore an impressive bulk of data has been obtained in vitro and in vivo concerning the recently recognized importance of endothelins as regulatory factors in various endocrine tissues. Although endothelin-1 is secreted mainly abluminally [2] and may play a paracrine rather than an endocrine role, experiments evaluating the effects of pharmacological doses in man may help to interpret the effect of increased plasma concentrations of ET-1 which have been observed in various clinical conditions [3]. However, due to the difficulty arising from the use of such a potent vaso-pressor agent on an experimental basis in humans comparatively few such experiments have been performed in man.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411–415

    Article  PubMed  CAS  Google Scholar 

  2. Wagner OF, Christ G, Wojta J, Vierhapper H, Parzer S, Nowotny PJ, Schneider B, Waldhäusl W, Binder BR (1992) Polar Secretion of Endothelin-1 by Cultured Endothelial Cells. J Biol Chem 267:16 066–16 068

    Google Scholar 

  3. Hutchison FN (1989) Endothelin: a new role for an old friend? J Lab Clin Med 122: 126–127

    Google Scholar 

  4. Vierhapper H, Wagner O, Nowotny P, Waldhäusl W (1990) Effect of endothelin-1 in man. Circulation 81: 1415–1418

    Article  PubMed  CAS  Google Scholar 

  5. Rabelink TJ, Kaasjager KAH, Boer P, Stroes EG, Braam B, Koomans HA (1994) Effects of Endothelin-1 on renal function in humans: implications for physiology and pathophysiology. Kidney Int 46: 376–381

    Article  PubMed  CAS  Google Scholar 

  6. Sorensen SS, Madsen JK, Pedersen EB (1994) Systemic and renal effect of intravenous infusion of endothelin-i in healthy human volunteers. Am J Physiol 266: F411 - F418

    PubMed  CAS  Google Scholar 

  7. Goetz KL, Wang BC, Madwed JB, Zhu JL, Leadley RJ (1988) Cardiovascular, renal, and endocrine responses to intravenous endothelin in conscious dogs. Am J Physiol 255: R1064 - R1068

    PubMed  CAS  Google Scholar 

  8. Vierhapper H, Wagner OF, Nowotny P, Waldhäusl W (1992) Effect of endothelin-i in man: pretreatment with nifedipine, with indomethacin and with cyclosporine A. Eur J Clin Invest 22: 55–59

    Article  PubMed  CAS  Google Scholar 

  9. Donckier JE, Hanet C, Berbinschi A, Galanti L, Robert A, Van Mechelen H, Pouleur H, Ketelslegers J-M (1991) Cardiovascular and endocrine effects of endothelin-i at pathophysiological and pharmacologica plasma concentrations in conscious dogs. Circulation 84: 2476–2484

    PubMed  CAS  Google Scholar 

  10. Webb DJ, Haynes WG (1993) Venoconstriction to endothelin-i in humans is attenuated by local generation of prostacyclin but not nitric oxide. J Cardiovasc Pharmacol 22: 5317–5320

    Article  Google Scholar 

  11. Haynes WG, Webb DJ (1993) Venoconstriction to endothelin-i in humans: role of calcium and potassium channels. Am J Phyciol 265: H1676 - H1681

    CAS  Google Scholar 

  12. Blöchl-Daum B, Vierhapper H, Eichler H-G, Waldhäusl W (1992) Endothelin-induced venoconstriction is unaffected by type 2-diabetes: in vivo effect of histamine on the endothelin action on veins. Arch Int Pharmacodyn 316: 90–96

    PubMed  Google Scholar 

  13. Kiowski W, Löscher TF, Linder L, Bühler FR (1991) Endothelin-i-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor. Circulation 83: 469–475

    Google Scholar 

  14. Kiowski W, Linder L, Stoschitzky K, Pfisterer M, Burckhardt D, Burkart F, Bühler FR (1994) Diminished vascular response to inhibition of endothelium-derived nitric oxide and enhanced vasoconstriction to exogenously administered endothelin-i in clinically healthy smokers. Circulation 90: 27–34

    PubMed  CAS  Google Scholar 

  15. Dahlöf B, Gustafsson D, Hedner T, Jern S, Hansson L (1990) Regional haemodynamic effects of endothelin-i in rat and man: unexpected adverse reaction. J Hypertens 8: 811–817

    Article  PubMed  Google Scholar 

  16. Vierhapper H, Hollenstein U, Roden M, Nowotny P (1993) Effect of endothelin-, in man - impact on basal and stimulated concentrations of LH, FSH, TSH, GH, ACTH and PRL. Metabolism 42: 902–906

    Google Scholar 

  17. Nayler WG, Gu XH, Casley DJ, Panagitopoulos S, Liu J, Mottram PL (1990) Cyclosporine increases endothelin-i binding site density in cardiac cell membranes. Biochem Biophys Res Commun 163: 1270–1274

    Article  Google Scholar 

  18. Wagner OF, Vierhapper H, Gasic S, Nowotny P, Waldhäusl W (1992) Regional effects and clearance of endothelin-i across pulmonary and splanchnic circulation. Eur J Clin Invest 22: 277–282

    Article  PubMed  CAS  Google Scholar 

  19. Weitzberg E, Ahlborg G, Lundberg JM (1993) Differences in vascular effects and removal of endothelin-i in human lung, brain, and skeletal muscle. Clin Physio113: 653–662

    Google Scholar 

  20. Gasic S, Wagner OF, Vierhapper H, Nowotny P, Waldhäusl W (1992) Regional hemodynamic effects and clearance of endothelin-i in humans: renal and peripheral tissues may contribute to the overall disposal of the peptide. J Cardiovasc Pharmacol 19: 176–180

    Article  PubMed  CAS  Google Scholar 

  21. Wagner OF, Nowotny P, Vierhapper H, Waldhäusl W (1990) Determination of endothelin-i in human plasma: arterio-venous differences and release during venous stasis. Eur J Clin Invest 20: 502–505

    Article  PubMed  CAS  Google Scholar 

  22. Druml W, Steltzer H, Waldhäusl W, Lenz K, Hammerle A, Vierhapper H, Gasic S, Wagner OF (1993) Endothelin-i in adult respiratory distress syndrome. Am Rev Respir Dis 148: 1169–1173

    PubMed  CAS  Google Scholar 

  23. Cozza EN, Gomez-Sanchez CE, Foecking MF, Chiou S (1989) Endothelin binding to cultured adrenal zona glomerulosa cells and stimulation of aldosterone secretion. J Clin Invest 84: 1032–1035

    Article  PubMed  CAS  Google Scholar 

  24. Rosolowsky LJ, Campbell WB (1990) Endothelin enhances adrenocorticotropin-stimulated aldosterone release from cultured bovine adrenal cells. Endocrinology 126: 1860–1866

    Article  PubMed  CAS  Google Scholar 

  25. Vierhapper H, Nowotny P, Waldhäusl W (1995) Effect of endothelin-i in man–impact on basal and ACTH-stimulated concentrations of aldosterone. J Clin Endocrin Metab 80: 948–951

    Article  CAS  Google Scholar 

  26. Takahashi K, Ghatei MA, Jones PM, Murphy JK, Lam H-C, O’Halloran DJ, Bloom SR (1991) Endothelin in human brain and pituitary gland. Presence of immunoreactive endothelin, endothelin messenger ribonucleic acid, and endothelin receptors. J Clin Endocrinol Metab 72: 693–699

    Article  PubMed  CAS  Google Scholar 

  27. Samson WK, Skala KD, Alexander BD, Huang F-L S (1990) Pituitary site of action of endothelin: selective inhibition of prolactin release in vitro. Biochem Biophys Res Comm 169: 737–743

    Article  PubMed  CAS  Google Scholar 

  28. Stojilkovic SS, Merelli F, Iida T, Krsmanovic LZ, Catt KJ (1990) Endothelin stimulation of cytosolic calcium and gonadotropin secretion in anterior pituitary cells. Science 248: 1663–1666

    Article  PubMed  CAS  Google Scholar 

  29. Hirai M, Miyabo S, Ooya E, Miyanaga K, Aoyagi N, Kimura K, Kishida S, Nakai T (1991) Endothelin-3 stimulates the hypothalamic-pituitary-adrenal axis. Life Sci 48: 2359–2263

    Article  PubMed  CAS  Google Scholar 

  30. Moretto M, Lopez FJ, Negro-Vilar A (1993) Endothelin-3 stimulates luteinizing hormone-releasing hormone ( LHRH) secretion from LHRH neurons by a prostaglandin-dependent mechanism. Endocrinology 132: 789–794

    Article  PubMed  CAS  Google Scholar 

  31. Hirata Y, Matsunaga T, Ando K, Furukawa T, Tsukagoshi H, Marumo F (1990) Presence of endothelin-i-like immunoreactivity in human cerebrospinal fluid. Biochem Biophys Res Commun 166: 1274–1278

    Article  PubMed  CAS  Google Scholar 

  32. Yamaji T, Johshita H, Ishibashi M, Takaku F, Ohno H, Suzuki N, Matsumoto H, Fujino M (1990) Endothelin family in human plasma and cerebrospinal fluid. J Clin Endocrinol Metab 71: 1611–1615

    Article  PubMed  CAS  Google Scholar 

  33. Kanyicska B, Burris TP, Freeman ME (1991) Endothelin-3 inhibits prolactin and stimulates LH, FSH and TSH secretion from pituitary cell culture. Biochem Biophys Res Commun 174: 338–343

    Article  PubMed  CAS  Google Scholar 

  34. Vierhapper H, Hollenstein U, Gessl A, Roden M, Nowotny P, Waldhäusl W (1994) Effect of endothelin-i on basal and stimulated concentrations of pituitary hormones in healthy men with and without pretreatment with nifedipine. 38th symposium, Deutsche Gesellschaft für Endokrinologie, Würzburg, 2–5 March 1994. Exp Clin Endocrinol 102 [Suppl 1]: 116 (abstract)

    Google Scholar 

  35. Gross PM, Wainman DS, Espinosa FJ (1991) Differentiated metabolic stimulation of rat pituitary lobes by peripheral and central endothelin-i. Endocrinology 129: 1110–1112

    Article  PubMed  CAS  Google Scholar 

  36. Calogero AE, Raiti F, Nicolosi G, Burrello N, D’Agata R, Mantero F (1994) Effects of endothelin-i and endothelin-3 on rat hypothalamic corticotrophin-releasing hormone and pituitary ACTH release in vitro. J Endocrinol 140: 419–424

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. H. Vierhapper
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung Kardiologie, Inselspital, 3010, Bern, Switzerland

    Thomas F. Lüscher

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Vierhapper, H. (1995). Systemic and Endocrine Effects of Endothelin in Humans. In: Lüscher, T.F. (eds) The Endothelium in Cardiovascular Disease. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79803-0_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-79803-0_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-79805-4

  • Online ISBN: 978-3-642-79803-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation